InvestorsHub Logo
Followers 9
Posts 750
Boards Moderated 0
Alias Born 10/19/2008

Re: Paulness post# 6360

Thursday, 11/09/2017 8:01:17 AM

Thursday, November 09, 2017 8:01:17 AM

Post# of 6599
I hope the company posts the paper or transcript of the presentation. I can not get to Washington this weekend, I would have loved to attend the conference.

I have also recently asked the Micheal J Fox foundation if they have been aware of the work at Florey. I never got all the details on the efficacy shown in the primate studies with Duke. I am thrilled with the human trials because with humans, you can get patient feedback in a much more detailed manner.

Six months is still early, but if the lower dose initial safety study levels show some notable efficacy in this 6 month milestone, then they really have something going forward that could truly help people.

Best of luck to all. I know investors want to make money here, but the biggest reward would be the improvement in and longevity of the patients lives............

HS
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ISCO News